CJD is caused by a proteinaceous infectious agent, or prion. CJD is related to other human transmissible spongiform encephalopathies (TSEs), including kuru (US incidence, 0 [now eradicated]), Gerstmann-Straüssler-Scheinker syndrome (US incidence, 1 case per 40 million population per year), and fatal familial insomnia syndrome (incidence, !1 case per 40 million population per year). Prion diseases elicit no immune response, result in a noninflammatory pathologic process confined to the central nervous system, have an incubation period of years, and usually are fatal within 1 year after diagnosis.
A variant form of CJD (vCJD) has been recognized that is acquired from cattle with bovine spongiform encephalopathy (or "mad cow disease"). As of July 2009, a total of 211 cases of vCJD have been reported worldwide: 165 in the United Kingdom, 25 in France, 5 in Spain, 4 in Ireland, 3 each in the United States and the Netherlands, 2 in Portugal, and 1 each in Italy, Canada, Japan, and Saudi Arabia. [4] [5] [6] Two of the patients from Ireland, 2 patients from the United States, and 1 patient each from Canada, France, and Japan are believed to have been exposed to bovine spongiform encephalopathy during their past residence in the United Kingdom; the third US patient likely acquired vCJD in Saudia Arabia. Patients with vCJD are younger than patients with CJD (median age at death, 28 vs 68 years), have a longer duration of illness (14 months vs !6 months), and usually present with psychiatric or sensory symptoms that are uncommon with CJD. The association of vCJD with bovine spongiform encephalopathy is the first instance of apparent transmission of a TSE across the species barrier to humans. Chronic wasting disease of deer and elk was recognized in the United States more than 20 years ago. It has been identified in several states, beyond its original area of occurrence in the Rocky Mountains. To date, no evidence for transmission of chronic wasting disease of deer and elk to humans has been identified. [7] [8] [9] [10] transmission of cjd via medical devices CJD occurs as both a sporadic disease (∼85% of cases) and as a familial or inherited disease (∼15% of cases). Fewer than 1% of cases of CJD have resulted from healthcare-associated transmission; the majority of these result from the use of contaminated tissues or grafts. 11 Iatrogenic CJD has been described in humans in 3 circumstances: in patients for whom contaminated medical equipment was used during intracranial placement of contaminated electroencephalography electrodes (2 cases in Switzerland) or neurosurgical procedures (4 suspected cases: 3 cases in the United Kingdom and 1 case in France), in patients who received hormone therapy with cadaveric human growth hormone or gonadotropin (1190 cases [26 cases in the United States]; since 1985, human growth hormone has been manufactured by the use of recombinant DNA technology, which eliminated this risk), and in patients who received an implant of contaminated grafts from humans (cornea, 2 cases; dura mater, 1190 cases [3 cases in the United States for which the risk factor is the Lyodura graft {B. Braun Melsungen} processed before 1987]). [11] [12] [13] [14] All known instances of iatrogenic CJD have resulted from exposure to infectious brain, pituitary, or eye tissue. Tissue infectivity studies in experimental animals have determined the infectiousness of different body tissues (Table  1) . 14, 15 Transmission to 2 patients via stereotactic electrodes is the only proven example of transmission by way of a medical device. The electrodes had been implanted in a patient with known CJD and then cleaned with benzene and "sterilized" with 70% alcohol and formaldehyde vapor produced by a formaldehyde generator using solid paraformaldehyde. Two years after the transmission to the 2 patients, these electrodes were retrieved and implanted into the brain of a chimpanzee, which subsequently developed the disease. 21 The method used 15 with information from other studies. [16] [17] [18] [19] [20] a High risk indicates a rate of transmission to inoculated animals of 150%; low risk indicates a rate of transmission to inoculated animals of x10%-20% (except for lung tissue, for which transmission is 50%); no risk indicates a rate of transmission to inoculated animals of 0% (several tissues in this category had few tested specimens).
to "sterilize" these electrodes would not now be considered an adequate method for sterilizing medical devices. The fact that no known cases of CJD transmitted by way of contaminated medical devices have occurred in the past several decades probably reflects the inefficiency of transmission unless neural tissue is involved, and the effectiveness of conventional cleaning and current disinfection and sterilization procedures, although suboptimal, may be adequate to prevent disease transmission. 11, 16 Retrospective studies suggest that 4 other cases of CJD may have resulted from the use of contaminated instruments in neurosurgical operations. 14, 22, 23 In one case the surgical instruments were cleaned with soap and water and then exposed to dry heat for an unspecified time at an unspecified temperature. 23 All 6 cases of CJD associated with neurosurgical instruments occurred in Europe during the period from 1952 through 1976, and details of the methods used to reprocess the instruments are incomplete. 11 Casecontrol studies have been performed to evaluate whether a proportion of sporadic cases of CJD result from covert, lowlevel contamination events during surgical procedures, and these studies have provided conflicting results. 24 In a series of cases, no secondary iatrogenic cases could be attributed to reuse of ophthalmic surgical instruments. 25 There are no known cases of sporadic CJD attributable to the reuse of devices contaminated with blood or to the transfusion of blood products. 26 
inactivation of the cjd prion
The prions that cause CJD and other TSEs exhibit an unusual resistance to conventional chemical and physical decontamination methods. Because the CJD agent is not readily inactivated by means of conventional disinfection and sterilization procedures and because of the invariably fatal outcome of CJD, the procedures for disinfection and sterilization of the CJD prion have been both cautious and controversial for many years.
The inactivation of prions by means of disinfection and sterilization processes has been studied by several investigators (Tables 2 and 3 ), but, until recently, these studies have not reflected the reprocessing procedures used in a clinical setting. First, these studies have not incorporated a cleaning procedure employing alkaline or enzymatic detergents, which normally reduces microbial contamination by a factor 53,54 of 4-6 log 10 and reduces protein contamination. [55] [56] [57] [58] While prions have been shown to bind tightly to surfaces and to be difficult to remove by cleaning, 59 there are now numerous studies that have shown the effectiveness of specific formulations of alkaline and enzymatic detergents to eliminate the infectivity of prions. [27] [28] [29] [30] [31] [32] [60] [61] [62] [63] [64] [65] [66] [67] Caution must be exercised in the use of enzymatic detergents with prion-contaminated instruments, since some enzymatic detergents have been shown to be prionicidal while others have been shown to increase resistance to subsequent inactivation by steam sterilization. 29, 33 Second, the prion studies have been performed with tissue homogenates, and the protective effect of tissue may explain, in part, why the CJD agent is difficult to inactivate. 68 When testing the efficacy of autoclaving, some investigators employed procedures such as using "lumps" of prion-infected tissue of 50 or 375 mg; they found that the larger tissue samples were more refractory to inactivation. 69 Brain homogenates have been shown to confer thermal stability to small subpopulations of the scrapie agent and some viruses. 68 However, surgical instruments that had been processed in the central processing departments of 5 hospitals were shown to have a median protein contamination level of 8-91 mg per instrument. 70 Given a scenario in which there is 100 mg of protein on an instrument and given that brain tissue from a person infected with CJD has a titer of 10 5 (mean infectivity calculated from a total group of 27; 50% lethal dose intracerebral units per gram), 15 the instrument would have 10 potentially infectious units, without considering the prionicidal activity of the reprocessing steps. Clearly, special prion reprocessing measures discussed in this guideline will eliminate the prion infectivity with a substantial margin of safety. This small number of infectious units is unlikely to be a hazard even with standard instrument reprocessing. However, on the basis of current knowledge, special prion reprocessing should be used to provide the greatest margin of safety.
Third, results of inactivation studies of prions have been variable because of the use of differing methods, which may have varied according to prion strain (eg, the differing thermostability of TSEs such as scrapie prion strain 263K or 22A note. The same process may be listed as both effective and ineffective because of differences in sterilant concentration, exposure time, temperature, etc, or differences in testing methods. All of these experiments were performed without cleaning. Modified from Rutala and Weber, 16 with information from other studies. or ME7, bovine spongiform encephalopathy prion strain 6PB1 or 301V, vCJD prion, and sporadic CJD prion), prion concentration, prion detection, 34 tissue or composition of the brain material tested (intact brain tissue, brain homogenates, or partially purified preparations), animals tested, surfaces tested (eg, plastic or stainless steel), testing method (in vivo or vitro [eg, Western blot]), duration of follow-up of inoculated animals, exposure container (eg, open or closed), method of calculating log 10 reductions in infectivity, concentration of the disinfectant at the beginning and end of the experiment, cycle parameters of the sterilizer, type of sterilizer (eg, gravity vs vacuum or porous steam sterilizers), and exposure conditions. Methodological issues have been found to significantly affect the antimicrobial testing results for all pathogens [71] [72] [73] [74] [75] [76] and likely explain the varying results seen with various chemical disinfection methods (eg, use of sodium hydroxide [NaOH] or chlorine) and sterilization methods (eg, steam sterilization at 134ЊC for 18 minutes vs exposure to NaOH plus steam sterilization). Despite these limitations, there is a consistent pattern in the results. 16, 77 On the basis of the disinfection studies, many, but not all, disinfection processes fail to inactivate clinically important numbers of prions (Table 3) . 16, [27] [28] [29] [30] [31] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] There are several chemicals that reduce the prion titer by 13 log 10 in 1 hour, but few of them have been used as disinfectants in healthcare facilities (Table 3) . Of these chemical compounds, chlorine and NaOH have provided the most consistent prion inactivation results. 16 However, both NaOH and chlorine are corrosive and unsuitable for semicritical devices, such as endoscopes.
Several recent studies have demonstrated that prions are inactivated by cleaners such as alkaline detergents and enzymatic detergents. 17, [27] [28] [29] [30] 32, 40, 48, [60] [61] [62] [63] [64] [65] [66] [67] Many of these studies used surgical stainless steel wires that were experimentally contaminated with prions; the contaminated wires efficiently transmitted the prion disease after implantation in the brains of mice or hamsters. 28, 29, 32, 33, 36, 49, 78 Several reports have demonstrated the possibility that available decontamination procedures using alkaline or enzymatic detergents (eg, Klenz-
40,48 could significantly reduce the infectivity of TSE agents (eg, scrapie prion strain 263K) and thus minimize or prevent the risk of iatrogenic transmission of undiagnosed or misdiagnosed CJD. 17, 27, 28, 36, 40, 48, 60, 63, 64, 66, 79, 80 Other studies have revealed that specific phenolic compositions 27, 28, 81, 82 or sodium dodecyl sulfate plus acetic acid may prove to be potent reagents for inactivation of prions. 37, 79 It seems clear that the use of specific formulations of alkaline or enzymatic detergents in combination with standard sterilization processes could lead to the development of a validated method for the sterilization of prion-contaminated medical devices. 17, 29, 30, 37, 40, 60, 64, 80 Prions also exhibit an unusual resistance to conventional physical decontamination methods (Table 2) .
16,27-52 While there is some disagreement on the ideal time and temperature cycle for autoclaving, the recommendation of 134ЊC for at least 18 minutes (prevacuum) or 132ЊC for 60 minutes (gravity displacement) is based on the scientific literature. [29] [30] [31] [32] [33] 41, [43] [44] [45] 47, 51, 52, 89, 83 Some investigators have also found that combining sodium hydroxide (eg, 0.09N or 0.9N for 2 hours) with steam sterilization for 1 hour at 121ЊC results in partial or complete loss of infectivity. 29, 41, 47 However, the combination of exposure to NaOH and steam sterilization may be deleterious to surgical instruments 77, 90 and sterilizers (T. K. Moore, written communication, October 2002), as well as to sterilizer operators, who could be breathing vaporized chemicals unless engineering controls or use of personal protective equipment prevents exposure. This risk can be minimized by the use of polypropylene containment pans and lids designed so that condensation collects and drips back into the pan. 90 Hot NaOH (250ЊF) is more caustic than NaOH at room temperature, so even greater care should be taken to avoid exposure to it (D. Asher, written communication, November 2002).
Until recently, low-temperature sterilization technologies (eg, use of ethylene oxide) have not demonstrated their effectiveness at inactivating prions (Table 2 ) and have not been used to sterilize prion-contaminated medical instruments. Several peer-reviewed studies have revealed that newer low-temperature sterilization technologies (ie, hydrogen peroxide gas plasma used in the Sterrad NX [ASP] and vaporized hydrogen peroxide) can eliminate the infectivity of prions on stainless steel wires and may be useful for reducing (or preventing) risk associated with prion-contaminated devices. 29, 32, 33, 36 These technologies, combined with use of prionicidal detergents, should sterilize prion-contaminated heat-sensitive medical devices, but a recommendation for using these technologies will be withheld until corroborative studies are published. 27, 32, 33, 36 decontamination, disinfection, and sterilization of prioncontaminated medical devices For a surgical instrument to act as a vehicle of prion transmission, it must come into contact with infective tissue (eg, brain) during surgery of the infected patient, it must retain the infectivity of any adhered matter after being decontaminated and sterilized, and it must have contact with the receptive tissue in the recipient. 91 The disinfection and sterilization recommendations for CJD in this guideline should break this chain of events and are based on the belief that infection prevention measures should be predicated on epidemiologic evidence linking specific body tissues or fluids to transmission of CJD; infectivity assays that demonstrate that body tissues or fluids are contaminated with infectious prions; cleaning data based on the use of detergents, microbiological indicators, and proteins; [54] [55] [56] [57] prion inactivation data; the risk of disease transmission with the use of the instrument or device; and a review of other recommendations. 12, 16, 92, 93 Other CJD sterilization recommendations have been based primarily on inactivation studies. 53, 77, 94 The 3 parameters integrated into disinfection and sterilization processing for prion-contaminated medical instruments are the patient's risk of having a prion disease, the comparative infectivity of different body tissues, and the intended use of the medical device. 16, 92, 93 High-risk patients include those with known prion disease; patients with rapidly progressive dementia consistent with possible prion disease; patients with a familial history of CJD, Gerstmann-Straüssler-Scheinker syndrome, or fatal familial insomnia syndrome; patients with a a known mutation in the PrP gene, which is involved in familial TSEs; patients with a history of dura mater transplantation; patients with electroencephalography findings or laboratory evidence suggestive of a TSE (eg, markers of neuronal injury such as 14-3-3 protein); and patients with a known history of cadaver-derived pituitary hormone injection. Tissues at high risk of carrying prions include those of the brain, spinal cord, pituitary gland, and posterior eye (including the retina or optic nerve). All other tissues are considered to have low or no risk (Table 1) . Critical devices are any that enter sterile tissue or the vascular system (eg, surgical instruments). Semicritical devices are those that con-tact nonintact skin or mucous membranes (eg, gastrointestinal endoscopes). The practices recommended by the Association of peri-Operative Registered Nurses and the Association for the Advancement of Medical Instrumentation for reprocessing surgical instruments exposed to CJD are consistent with the following recommendations. 16, 95, 96 Recommendations for disinfection and sterilization of prion-contaminated medical devices are as follows. Instruments should be kept wet (eg, immersed in water or a prionicidal detergent) or damp after use and until they are decontaminated, and they should be decontaminated (eg, in an automated washer-disinfector) as soon as possible after use. Dried films of tissue are more resistant to prion inactivation by means of steam sterilization than are tissues that are kept moist. This may be related to the rapid heating that occurs in the film of dried material compared with the bulk of the sample, and to the rapid fixation or dehydration of the prion protein in the dried film. 31 It seems that prions in the dried portions of brain macerates are less efficiently inactivated than prions in undisturbed tissue. In addition, certain disinfectants (eg, glutaraldehyde, formaldehyde, or ethanol) can fix or dehydrate the protein and make it more difficult to inacti vate. 51, 69, 97, 98 A procedure using formalin together with formic acid has been proposed for the preparation of tissue samples obtained from patients with CJD. 99 The high resistance of prions to standard sterilization methods warrants special procedures in the reprocessing of surgical instruments. Special prion reprocessing is necessary when reprocessing critical or semicritical medical devices that have had contact with high-risk tissues from high-risk patients. After the device is clean, it should be sterilized by either autoclaving (ie, steam sterilization) or using a combination of sodium hydroxide and autoclaving, 12 using 1 of the 4 options below: Option 1. Autoclave at 134ЊC for 18 minutes in a prevacuum sterilizer.
Option 2. Autoclave at 132ЊC for 1 hour in a gravity displacement sterilizer.
Option 3. Immerse in 1 N NaOH (1 N NaOH is a solution of 40 g NaOH in 1 L water) for 1 hour; remove and rinse in water, then transfer to an open pan and autoclave (121ЊC gravity displacement sterilizer or 134ЊC porous or prevacuum sterilizer) for 1 hour.
Option 4. Immerse in 1 N NaOH for 1 hour and heat in a gravity displacement sterilizer at 121ЊC for 30 minutes, then clean and subject to routine sterilization.
Some data suggest that the temperature should not exceed 134ЊC, since under certain conditions the effectiveness of autoclaving actually declines as the temperature is increased (eg, to 136ЊC or 138ЊC), 52 but other data do not demonstrate reduced effectiveness with increasing temperature (eg, 138ЊC). 69 While 6 options were included in the World Health Organization conference of 1999, in the current recommendations we have included only those options for which scientific studies have best demonstrated both safety (for equipment and operator) and efficacy. It is unclear from the published literature which of these options is the best for complete inactivation of prions, because some studies have revealed excellent but not complete inactivation of the test prions with autoclaving only (options 1 and 2) and the same result for use of NaOH and autoclaving (options 3 and 4). This is likely explained by methodological differences between the studies, but the studies that used the same method for evaluating both autoclaving (option 1) and use of NaOH plus autoclaving (option 3) revealed similar results. 29, 30, 32, 33, 89 It is essential with any sterilization process, and especially when prion-contaminated devices are involved, that the instrument be fully accessible to the sterilant (eg, steam). 30 Prion-contaminated medical devices that are impossible to clean or fully expose to steam and other sterilants should be discarded. Flash sterilization should not be used for reprocessing. Always discard single-use devices. To minimize environmental contamination, noncritical environmental surfaces should be covered with plastic-backed paper, and if the paper has been contaminated with high-risk tissues, it should be properly discarded (eg, as nonregulated medical waste). There are no antimicrobial products registered by the Environmental Protection Agency (EPA) specifically for inactivation of prions on environmental surfaces, and there are no sterilization processes cleared by the Food and Drug Administration for sterilization of reusable surgical instruments. However, the EPA has issued quarantine exemptions to several states that permit the temporary use of a phenolic (containing 6.4% ortho-benzyl-para-chlorophenol, 3.0% para-tertiary-amylphenol, 0.5% ortho-phenyl phenol, 4.9% hexylene glycol, 12.6% glycolic acid, and 8% isopropanol) 81 for inactivation of prions on hard, nonporous surfaces in laboratories that handle contaminated or potentially contaminated animal tissues and wastes. If no EPA-registered or exempted products are available, then noncritical environmental surfaces (eg, laboratory surfaces) contaminated with high-risk tissues (eg, brain tissue) should be cleaned and then spot decontaminated with a 1 : 5 to 1 : 10 dilution of hypochlorite solutions, ideally for a contact time of at least 15 minutes. [42] [43] [44] 79, 83, 84, 100 No recommendation can be made regarding the use of special prion reprocessing for reprocessing critical or semicritical devices contaminated with low-risk tissues from highrisk patients. Although low-risk tissue has been found to transmit CJD at a low frequency (Table 1) , this has been demonstrated only when low-risk tissue is inoculated into the brain of a susceptible animal. In humans, medical instruments contaminated with low-risk tissue would be unlikely to transmit infection after standard cleaning and sterilization, since the instruments would not be used in the central nervous system. Environmental surfaces contaminated with lowrisk tissues from high-risk patients require only standard disinfection. 16, 92, 93 Since noncritical surfaces are not involved in disease transmission, the normal exposure time (x1 minute) is recommended.
To minimize the possibility of using neurosurgical instruments that potentially were contaminated during procedures performed on patients in whom CJD was later diagnosed, healthcare facilities should consider using the sterilization guidelines outlined below for neurosurgical instruments used during brain biopsy performed on patients in whom a specific lesion (eg, a suspected tumor or abscess) has not been demonstrated (eg, by magnetic resonance imaging or computed tomography scans). Alternatively, disposable neurosurgical instruments should be used for such patients, 16 or the instruments could be quarantined until the pathologic findings of the brain biopsy are reviewed and the diagnosis of CJD is excluded. If disposable instruments are used, they should be of the same quality as reusable devices. Some countries (eg, France and Switzerland) have implemented enhanced sterilization rules to prevent the transmission of CJD by means of surgical instruments, requiring steam sterilization at 134ЊC for 18 minutes for all surgical instruments. Other countries (eg, United Kingdom) discard all surgical instruments used on high-risk tissues from patients known to have CJD. 64 When a neuropathologic diagnosis of unsuspected CJD is made on the basis of a brain biopsy or at the time of autopsy, instruments used on high-risk tissues of the patient should be recalled and reprocessed using special prion reprocessing methods. To enhance the ability to recall such instruments, ideally institutions should have a tracking system in place that permits recall of critical or semicritical devices used on high-risk tissue and high-risk patients. This tracking system should permit identification of the patient on which the devices were used, the date they were used, the procedure performed, and the surgeon's name. 96 The decision whether to notify patients on whom such instruments were used should be based on an analysis of the risk of CJD transmission. [102] [103] [104] Most of the data that form the basis of these recommendations have been generated from studies of the prions responsible for sporadic CJD, vCJD, or animal TSE diseases (eg, scrapie and bovine spongiform encephalopathy). To date, there have been no reports of human-to-human transmission of vCJD by tissue, but 4 possible cases of vCJD transmitted by blood transfusion have been reported. [105] [106] [107] [108] Unlike sporadic CJD, patients with vCJD have infectivity detectable in lymphoid tissue, such as the appendix, spleen, tonsils, thymus, and lymph nodes. Furthermore, vCJD infectivity may be detectable before the onset of clinical illness. Prion contamination of medical instruments has raised concern about the possible human-to-human transmission of vCJD by medical instruments contaminated with such tissues. On the basis of these concerns, the use of prion disinfection and sterilization guidelines (or use of single-use instruments) has been proposed in the United Kingdom for instruments used in dental procedures, 40 ,109 eye procedures, 110 or tonsillar surgery 111 on patients at high risk of having sporadic CJD or vCJD. Following complications (death in 1 patient and increased bleeding [1% with reusable instruments vs 12% for disposable instruments]) associated with the use of singleuse instruments in tonsillar surgery, 112 it is now advised in the United Kingdom that, given the balance of risk, surgeons can return to using reusable surgical equipment. If epidemiologic and infectivity data show that these tissues represent a transmission risk, then CJD sterilization precautions (or use of disposable equipment) could be extended to equipment used for these procedures. 113 standard precautions to prevent transmission from prioncontaminated instruments During the past 10 years, many researchers have searched for a method that inactivates prions on medical instruments yet can be applied to all instrument reprocessing so that special prion reprocessing would not be necessary. 17, 64 Some products (eg, alkaline detergents) have been independently certified by the European Community Notified Body, which means that the product has a "CE" marking but the manufacturer is relied on to assess the scientific qualities of the product. 40 Thus, the use of these products remains at the discretion of users, and the users should use detergents that have been shown to reduce infectivity.
17,27-,32,60-64 However, it seems that a number of alkaline and enzymatic detergents have proved to be as effective in eliminating prion infectivity as is 1 N NaOH, the method recommended by the World Health Organization. 48 The practical application of an alkaline detergent in a washerdisinfector followed by steam sterilization has been investigated and shown to eliminate prions from steel surfaces. 64 Ideally, this research will continue and will demonstrate the suitability of integrating new alkaline or enzymatic detergents into the current mechanical washers (eg, washer-disinfectors) in central processing departments, so that the inactivation provided by the detergent (ie, a 5-6 log 10 reduction in infectivity) added to the reduction offered by the sterilization process (eg, steam sterilization, 5-6 log 10 reduction) would eliminate the risks of transmitting infection by way of prioncontaminated medical or surgical instruments. When this goal is achieved, the need for special prion reprocessing will be eliminated. Until that time, this guideline should be updated periodically so that new methods of removing or inactivating prions from medical devices and new disinfection and sterilization practices can be included.
general infection prevention precautions
Standard precautions should be used for all patients with known or suspected CJD. Additional precautions (eg, contact precautions) are unnecessary. Gloves should be worn for handling of blood and body fluids. Masks, gowns, and protective eyewear should be worn if mucous membrane or skin exposure to blood or other material that is potentially infectious is anticipated. Laundry should be managed as required by the Occupational Safety and Health Administration (OSHA) rule on bloodborne pathogens. 114 No additional precautions are required. No special precautions are required for the handling of food utensils. Patients with known or suspected prion disease should not serve as donors for organs, tissues, blood components, or sources of tissue (eg, dura mater and hormones).
The use of standard precautions in central processing departments, in clinical laboratories, or during the processing of pathologic materials (including during autopsy) should preclude any possibility of CJD transmission to healthcare personnel. Thus, there is no need to decontaminate or discard instruments (eg, a washer-disinfector or a cerebrospinal fluid analyzer) whose internal components may have been contaminated with prions. However, external surfaces that are contaminated with high-risk tissue should be decontaminated as described.
No special precautions are required for the disposal of body fluids. Such fluids may be disposed of by means of a sanitary sewer. Disposable sheets used to cover work surfaces may be disposed of as nonregulated medical waste. Regulated medical waste (eg, bulk blood, pathologic waste, or sharp devices) should be managed according to state regulations. When a patient dies, ensure that the morgue and funeral home are notified that the patient had CJD. No excess precautions need to be taken with regard to burial (eg, no special cemetery is required).
There is no evidence of occupational transmission of CJD to a healthcare worker. Although cases of CJD have been reported in healthcare workers, the incidence does not exceed what would be expected from chance alone. 115 In the context of occupational exposure, the highest potential risk results from exposure to high-infectivity tissue through needlestick injuries with inoculation. Percutaneous exposure to the cerebrospinal fluid or brain tissue of an infected person can be followed by washing with detergent and copious water (avoid scrubbing), rinsing, and drying, although scientifically unproven to reduce risk. For maximum safety, consider briefly rinsing the wound with 0.5% sodium hypochlorite (or another chemical with prionicidal activity) and then rinsing with water. Mucous membrane exposure to infectious tissues or fluids should be managed by irrigating the mucous membrane thoroughly with saline for several minutes.
recommendations for processing cjd-contaminated patient-care equipment and environmental surfaces This section does not apply to vCJD.
We have used the system for categorizing the strength of recommendations that is currently used by the Centers for Disease Control and Prevention for Healthcare Infection Control Practices Advisory Committee recommendations (see Table 4 ).
A. Do not allow instruments to become dry after use. Dried films of tissue are more resistant to prion inactivation by steam sterilization than are tissues that have been kept moist. Keep instruments moist (either wet by immersion in water or a detergent with prionicidal activity or, if not possible, by use of a wet cloth draped over the instruments or use of a transport gel or foam) after use and during storage or transport prior to decontamination in central processing departments. Instruments should be decontaminated as soon as possible after use. Decontaminate instruments in a mechanical washer (eg, washer-disinfector) with a detergent (preferably a detergent that has been shown to have prionicidal activity), and after decontamination, sterilize by one of the methods shown to be effective and recommended below. 17 Option 2. Autoclave at 132ЊC for 1 hour in a gravity displacement sterilizer. 43, 47, 83, 89, 98 Option 3. Immerse in 1 N NaOH for 1 hour; remove and rinse in water, then transfer to an open pan and autoclave (121ЊC in a gravity displacement sterilizer or 134ЊC in a porous or prevacuum sterilizer) for 1 hour. 29, 32, 33, 41, 47, 89 Option 4. Immerse instruments in 1 N NaOH for 1 hour and heat in a gravity displacement sterilizer at 121ЊC for 30 minutes (to minimize autoclave and operator exposure to gaseous NaOH when immersing instruments and autoclaving in NaOH, the use of containers with a rim and lid designed for condensation to collect and drip back into the pan is recommended); then rinse and subject to routine sterilization. 90 2. Discard devices that are impossible to clean. 16, 57 (Category II.)
3. Do not use flash sterilization for reprocessing instruments. 16, 101 (Category IB.) 4. Discard items that permit only low-temperature sterilization (eg, sterilization with ethylene oxide). 84 (Category IB.)
5. No recommendation can be made regarding the use of low-temperature technologies that have shown prionicidal activity, such as a specific type of hydrogen peroxide gas plasma and vaporized hydrogen peroxide, as the data are limited and require corroboration. 27, 32, 36 (No recommendation: unresolved issue.) 6. Recall contaminated items (eg, medical devices used for brain biopsy before diagnosis) that have not been processed according to these recommendations and appropriately reprocess them. 16, 101 (Category II.) 7. To minimize patient exposure to neurosurgical instruments later determined to have been used on a patient with CJD, use the sterilization guidelines above for neurosurgical instruments used on patients undergoing brain biopsy when a specific lesion (eg, a suspected tumor or abscess) has not been demonstrated (by computed tomography or magnetic resonance imaging). Alternatively, use disposable neurosurgical instruments on such patients. 16 (Category IB.) 8. Clean noncritical environmental surfaces contaminated with high-risk tissues (eg, a laboratory surface in contact with brain tissue of a CJD-infected person) with a detergent and then spot decontaminate these surfaces with a 1 : 5 to 1 : 10 dilution of sodium hypochlorite (ie, bleach; a 1 : 5 dilution of 5.25%-6.15% sodium hypochlorite provides 10,500-12,300 ppm chlorine), ideally for a contact time of at least 15 minutes. To minimize environmental contamination, use disposable plasticbacked cover sheets on work surfaces. [42] [43] [44] 78, 79, 83, 84, 100 (Category IB.)
9. Clean and then disinfect noncritical equipment that has been contaminated with high-risk tissue using a 1 : 5 to 1 : 10 dilution of sodium hypochlorite or 1 N NaOH, depending on material compatibility. Ensure that all contaminated surfaces are exposed to the disinfectant. [42] [43] [44] 79, 83, 84, 100 (Category IB.) 10. If the operating surgeon believes that the patient is at risk for a TSE such as CJD, he or she should communicate that information to the operating room charge nurse, the anesthesiology staff, the neuropathology or clinical pathology laboratory staff, the risk manager, and the infection preventionist. Train clinicians and reprocessing technicians on how to properly tag the equipment and train them in the special prion reprocessing protocols. Because standard decontamination of tissue samples (eg, with formalin) or specimens may not inactivate CJD, all tissue samples should be handled with the use of standard precautions (ie, gloves). Tag equipment that requires special prion reprocessing after use.
The tissue samples and specimens should be labeled as a "biohazard" and as "suspected CJD" before being sent to the laboratory. 16 (Category IB.)
C. No recommendation can be made regarding the use of the procedures listed in recommendation B1-B10 for reprocessing of critical or semicritical medical devices that have been contaminated with low-risk tissues (defined as cerebrospinal fluid, kidney, liver, spleen, lung, placenta, olfactory epithelium, and lymph nodes) from high-risk patients. (No recommendation: unresolved issue.) D. Use only standard disinfection to process environmental surfaces contaminated with low-risk tissues. (Use disinfectants recommended by OSHA for disinfecting blood-contaminated surfaces.) 53, 101, 114 (Category IB.) E. Use the following recommended procedures to reprocess critical or semicritical medical devices that have been contaminated with no-risk tissue (defined as peripheral nerve, intestine, bone marrow, blood, leukocytes, serum, thyroid gland, adrenal gland, heart, skeletal muscle, adipose tissue, gingiva, prostate, testis, tears, saliva, sputum, urine, feces, semen, vaginal secretions, milk, sweat) from high-risk patients. 12, 15, 16, 18, 20, 53, 101, 114 (Category IB.)
1. Clean and either disinfect or sterilize these devices using conventional protocols of heat or chemical sterilization or high-level disinfection. (Category IB.) 2. Use standard cleaning and high-level disinfection protocols for reprocessing endoscopes (except neurosurgical endoscopes with central nervous system contact), because these devices can become contaminated only with no-risk materials. (Category IB.) 3. Use standard disinfection to process noncritical equipment and noncritical environmental surfaces that have been contaminated with no-risk tissues or fluids (use disinfectants recommended by OSHA for decontaminating blood-contaminated surfaces [eg, 1 : 10 to 1 : 100 dilution of 5.25%-6.15% sodium hypochlorite]). (Category IB.) F. A quality control program should be established and maintained that enhances healthcare worker performance (orientation, continuing education, and documented competency) and monitors disinfection and sterilization efficacy (eg, sterilizer maintenance and repair history; sterilization process monitoring by means of physical, chemical, and biological monitors; and disinfectant concentration). 96, 101, 117 (Category IB.)
